Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Nature
|
May 27, 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi, Chao Shan, Xiaomin Duan, et al.
Plos One
|
June 15, 2007
Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark
Kegong Tian, Xiuling Yu, Tiezhu Zhao, et al.
Nature Microbiology
|
April 3, 2019
Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus
Qihui Wang, Tong Ma, Yan Wu, et al.
The Lancet. Infectious Diseases
|
March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai, et al.
Cell
|
May 21, 2019
Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B
Xin Zhao, Guigen Zhang, Sheng Liu, et al.
Plos One
|
March 22, 2007
A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates
Chen Chen, Jiaqi Tang, Wei Dong, et al.
The Journal of Biological Chemistry
|
June 12, 2018
Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells
Hin Chu, Che-Man Chan, Xi Zhang, et al.
Emerging Microbes & Infections
|
March 21, 2022
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
Yaling An, Shihua Li, Xiyue Jin, et al.
Nature Communications
|
January 25, 2014
Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus
Lunbiao Cui, Di Liu, Weifeng Shi, et al.
The New England Journal of Medicine
|
May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Nature
|
May 27, 2020
A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2
Rui Shi, Chao Shan, Xiaomin Duan, et al.
Plos One
|
June 15, 2007
Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark
Kegong Tian, Xiuling Yu, Tiezhu Zhao, et al.
Nature Microbiology
|
April 3, 2019
Neutralization mechanism of human monoclonal antibodies against Rift Valley fever virus
Qihui Wang, Tong Ma, Yan Wu, et al.
The Lancet. Infectious Diseases
|
March 27, 2021
Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials
Shilong Yang, Yan Li, Lianpan Dai, et al.
Cell
|
May 21, 2019
Human Neonatal Fc Receptor Is the Cellular Uncoating Receptor for Enterovirus B
Xin Zhao, Guigen Zhang, Sheng Liu, et al.
Plos One
|
March 22, 2007
A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates
Chen Chen, Jiaqi Tang, Wei Dong, et al.
The Journal of Biological Chemistry
|
June 12, 2018
Middle East respiratory syndrome coronavirus and bat coronavirus HKU9 both can utilize GRP78 for attachment onto host cells
Hin Chu, Che-Man Chan, Xi Zhang, et al.
Emerging Microbes & Infections
|
March 21, 2022
A tandem-repeat dimeric RBD protein-based covid-19 vaccine zf2001 protects mice and nonhuman primates
Yaling An, Shihua Li, Xiyue Jin, et al.
Nature Communications
|
January 25, 2014
Dynamic reassortments and genetic heterogeneity of the human-infecting influenza A (H7N9) virus
Lunbiao Cui, Di Liu, Weifeng Shi, et al.
The New England Journal of Medicine
|
May 4, 2022
Efficacy and Safety of the RBD-Dimer-Based Covid-19 Vaccine ZF2001 in Adults
Lianpan Dai, Lidong Gao, Lifeng Tao, et al.
Page
of 17